Cargando…
Dipyridamole induces the phosphorylation of CREB to promote cancer cell proliferation
Dipyridamole, a traditional anti-platelet drug, has been reported to inhibit the proliferation of cancer cells. The present study aimed to investigate the possibility of dipyridamole as an adjuvant of chemotherapy by enhancing the cytotoxicity of an anti-cancer drug. The cytotoxicity of colorectal c...
Autores principales: | Abdelghany, Lina, El-Mahdy, Nageh, Kawabata, Tsuyoshi, Goto, Shinji, Li, Tao-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882894/ https://www.ncbi.nlm.nih.gov/pubmed/33664815 http://dx.doi.org/10.3892/ol.2021.12512 |
Ejemplares similares
-
Nicaraven induces programmed cell death by distinct mechanisms according to the expression levels of Bcl-2 and poly (ADP-ribose) glycohydrolase in cancer cells
por: Abdelghany, Lina, et al.
Publicado: (2022) -
MSK1 promotes cell proliferation and metastasis in uveal melanoma by phosphorylating CREB
por: Li, Jianchang, et al.
Publicado: (2019) -
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022) -
Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance
por: Goto, Shinji, et al.
Publicado: (2020) -
Phosphorylation of CREB-Specific Coactivator CRTC2 at Ser238 Promotes Proliferation, Migration, and Invasion of Colorectal Cancer Cells
por: Wang, Yi, et al.
Publicado: (2020)